The Canadian Food Inspection Agency (CFIA) recently issued a food recall notice. A self-owned brand frozen shrimp product sold by Walmart Canada was ordered to stop sales and be recalled due to the detection of prohibited veterinary drug metabolites.

  The involved product is the "Shrimp Ring with Mild Cocktail Sauce" of Our Finest series, a high-end private brand under Walmart, with a specification of 240 grams per box. CFIA testing found that the product contained 3-amino-2-oxazolidone (AOZ), which is a metabolite of the antibiotic Furazolidone.

  This recall of products is handled by Export Packers Company Limited, a Canadian aquatic products enterprise. The affected products are only sold in Ontario, Canada, with a retail price of 29.97 Canadian dollars.

  According to the information released by CFIA, consumers and retailers can identify the involved products through the following information: 

- Brand: Our Finest 

- Product Name: Shrimp Ring with Mild Cocktail Sauce 

- Net Content: 240 grams 

- UPC Code: 6 27735 264127 

- Product Code: 2027 JL 31 

- Recall Level: Class 3 Food recall

  The CFIA requires retailers not to continue selling, supplying, processing or distributing the relevant products. At present, the regulatory authorities have not received any disease reports related to this product.

  Our Finest is an important private label series of Walmart in the Canadian market, mainly selling mid-to-high-end products including food and frozen food. Walmart currently has over 400 stores in Canada. This recall involves frozen shrimp products sold within its retail system.

  Export Packers Company Limited is one of the larger aquatic product import and processing enterprises in Canada. Its business covers multiple categories such as shrimp, fish and shellfish, and supplies frozen seafood to retail channels. This recall incident has once again brought supply chain quality control into the spotlight of the market.

  In North American aquatic product trade, antibiotic residues have always been a key focus of import regulation. Markets such as the United States and Canada maintain strict testing requirements for banned drugs like nitrofurans and chloramphenicol. For shrimp products, the management of drug use in the breeding process, the screening of raw materials by processing enterprises, and pre-export testing all affect whether the products can enter the target market.

  In recent years, the global shrimp supply chain has become increasingly dependent on large retail channels, and brand owners usually impose higher food safety standards on their suppliers. A single drug residue issue not only involves the recall of a single batch of products, but may also affect the subsequent order review and market access of suppliers.

  The Canadian shrimp import market mainly relies on overseas supply. Many production areas in Asia and Latin America export frozen shrimp products to Canada. Export enterprises need to confront the residue standards and requirements of different countries and regions, especially in the European and American markets, which impose stricter demands on the management of aquaculture inputs and product traceability systems.

  The recalled Our Finest shrimp ring products have not been found to have consumer health problems so far, but the incident once again demonstrates the high sensitivity of the North American market to the safety testing of imported aquatic products. For export enterprises, drug residue control has become an important threshold for entering the large supermarket system.